HALT PKD Clinical Research
The Polycystic Kidney Disease Treatment Network (PKD-TN) has established the HALT PKD clinical trials to test interventions that may be
effective in slowing kidney growth in patients suffering from polycystic
kidney disease. Top investigators from a number of leading United States medical centers, with full support from the NIH National Institute of Diabetes & Digestive &
Kidney Diseases, are collaborating in HALT PKD clinical trials. The
Division of Biostatistics at
Washington University in St. Louis
served as the Data Coordinating
Center (DCC) through June 30, 2009, under the guidance of Professor J. Philip Miller,
and was responsible for developing the data entry
system, managing all study data, tracking patient recruitment and adverse
events, and overseeing data collection and reporting. The responsibilities
of the HALT PKD Data Coordinating Center were transferred to the University
of Pittsburgh Medical Center on July 1, 2009.
*Please note that final determination of
eligibility to participate in any clinical trial requires that the principal
investigator or his/her designate make a very subject-specific, case-by-case
assessment based on defined inclusion/exclusion criteria.
Resources for
Information on HALT PKD and Polycystic Kidney Disease
|
Participate recruitment to HALT PKD
has been completed.
 | For information on the current status
of the HALT PKD clinical trials, please email the Project Manager,
Patty Smith, at the University
of Pittsburgh Medical Center. You can also reach her by phone at (412)
692-2490.
|
 | Information on study participation may be found by referring to the
HALT
PKD study brochure - just click on the link below:.
|
 | HALT PKD:
Information for Physicians Brochure (pdf)
|
 | Study
participants are followed at 1 of 7 participating clinic sites,
assigned according to the state in which they live. |
|
Participants from these Eastern states
are followed at Tufts Medical Center or Beth Israel Deaconess Medical
Center:
Connecticut, Delaware, District of Columbia, Maine, Maryland,
Massachusetts, Pennsylvania, New Hampshire, New Jersey, New York,
Rhode Island, Vermont, or Virginia - please call:
Tufts Medical Center
– Boston, MA
1-866-846-2735
(toll-free)
Beth
Israel Deaconess Medical Center – Boston, MA
1-866-650-1815
(toll-free)
|
|
Participants from these Southern states are followed at Emory
University:
Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina,
South Carolina, or
Tennessee
- please call:
Emory
University – Atlanta, Georgia
1-404-686-8280 |
|
Participants from these Midwestern states
are followed at Mayo Clinic, Cleveland Clinic, or Kansas University
Medical Center:
Arkansas, Iowa, Illinois, Indiana, Kansas, Kentucky, Michigan,
Minnesota, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South
Dakota, West Virginia, or Wisconsin - please call:
Mayo Clinic –
Rochester, Minnesota
1-888-630-2616
(toll-free)
Cleveland
Clinic Foundation – Cleveland, Ohio
1-800-223-2273,
Ext. 44680
(toll-free)
Kansas
University Medical Center – Kansas City, Kansas
1-913-588-7609 |
|
Participants from these Western states
are followed at the University of Colorado:
Alaska,
Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New
Mexico, Oregon, Texas, Utah, Washington, or Wyoming - please call:
University
of Colorado Health Sciences Center
Denver, Colorado
1-877-765-9297
(toll-free) |
|